Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 24.59
-0.61 (-2.42%)
Sep 23, 2026, 3:00 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 5 billion as of September 23, 2026. Its market cap has decreased by -39.68% in one year.
Market Cap
5.00B
Enterprise Value
5.85B
Revenue
1.44B
Ranking
n/a
PE Ratio
23.79
Stock Price
24.59
ChartMarket Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 5.00B, a decrease of -38.59%. That is a compound annual growth rate of -8.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 5.00B | -20.24% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding